Pilot quality and safety

Safety and quality monitoring for the pilots is underpinned by 5 guiding principles:

1. Integration—Integrating quality and safety monitoring and reporting processes with existing frameworks to minimise duplication.
2. Transparent, open and just culture—Creating a just and open culture for consumers and staff to drive effective management of risks, incidents and feedback and to inform evaluation and continuous quality improvement.
3. Respect—Promoting approaches to communication and engagement with stakeholders that are respectful and ensure a collaborative approach to quality and safety.
4. Culturally safe—Ensuring quality and safety measures and reporting mechanisms that are culturally safe and accessible, to ensure culturally diverse stakeholders are equitably engaged.
5. Proactive—Taking a proactive and quality improvement approach to quality and safety, to identify and reduce risks and drive scalability and sustainability of the Pilot whilst ensuring safety in services.

The quality and safety mechanisms that are in place for the pilots involve a range of targeted activities, including:

• Proactive monitoring of a range of quality and safety indicators to identify continuous quality improvement opportunities.
• Surveillance monitoring of relevant processes and escalation pathways that are in place to monitor complaints, incidents and other notifications.
• Active management to address consumer and stakeholder feedback and incident reporting.

An established quality and safety reporting process is in place to escalate, manage, and review risks and issues that may arise throughout Pilot service delivery. This includes regular quality and safety reporting to the Pilot Quality and Safety Subcommittee, and the Pilot Governance Board.

Evaluation

Queensland Health has commissioned an external evaluation of both pilots, aligned to the Australian Institute of Health and Welfare dimensions of system performance: accessibility, continuity, effectiveness, efficiency and sustainability, appropriateness and safety.

The evaluations are being conducted by Deloitte in partnership with Griffith University academics and have received ethical approval through the Griffith University Human Research Ethics Committee.

The evaluations will use a mixed-methods approach to collecting and analysing data from a range of sources, including activity and administrative records and data collected from a range of stakeholders. These stakeholders include pharmacists, pharmacy owners, patients, other healthcare practitioners, and other relevant stakeholders (e.g. peak bodies, government, and consumer representative groups).

All data collected for evaluation purposes will be kept private and stored in secure online environments held by Deloitte and Griffith University. This information is only accessible to the evaluation team.

For detailed information about the approach to evaluation and what information will be collected, please see the Pilot Evaluation Consent Information Sheet (PDF, 182kB).

If you have questions about the evaluation of the pilots, please contact the evaluation team on email QCPSPPevaluation@deloitte.com.au or during business hours call (07) 3003 8230.